Harnessing Prebiotics to Improve Type 2 Diabetes Outcomes
Nutrients · 11.10.2024 · 16 (20) · 3447
DOI: 10.3390/nu16203447 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Nutrients, online erschienen am 11.10.2024. Verfasst von Oana C Iatcu und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biomedical Sciences, College of Medicine and Biological Science, University of Suceava, 720229 Suceava, Romania. Hauptthemen laut MEDLINE: Prebiotics, Diabetes Mellitus, Type 2, Gastrointestinal Microbiome, Dysbiosis. Die Arbeit wurde bisher 31-mal zitiert (Crossref) und nennt 259 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: European Regional Development Fund.
Themen: Diabetes mellitus
Abstract (Originalsprache)
The gut microbiota, a complex ecosystem of microorganisms in the human gastrointestinal tract (GI), plays a crucial role in maintaining metabolic health and influencing disease susceptibility. Dysbiosis, or an imbalance in gut microbiota, has been linked to the development of type 2 diabetes mellitus (T2DM) through mechanisms such as reduced glucose tolerance and increased insulin resistance. A balanced gut microbiota, or eubiosis, is associated with improved glucose metabolism and insulin sensitivity, potentially reducing the risk of diabetes-related complications. Various strategies, including the use of prebiotics like inulin, fructooligosaccharides, galactooligosaccharides, resistant starch, pectic oligosaccharides, polyphenols, β-glucan, and Dendrobium officinale have been shown to improve gut microbial composition and support glycemic control in T2DM patients. These prebiotics can directly impact blood sugar levels while promoting the growth of beneficial bacteria, thus enhancing glycemic control. Studies have shown that T2DM patients often exhibit a decrease in beneficial butyrate-producing bacteria, like Roseburia and Faecalibacterium, and an increase in harmful bacteria, such as Escherichia and Prevotella. This review aims to explore the effects of different prebiotics on T2DM, their impact on gut microbiota composition, and the potential for personalized dietary interventions to optimize diabetes management and improve overall health outcomes.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Biomedical Sciences, College of Medicine and Biological Science, University of Suceava, 720229 Suceava, Romania.
- Department of Basic Medical Sciences, College of Osteopathic Medicine, Western University of Health Sciences, Pomona, CA 91766, USA.
- Department of Internal Medicine, Scripps Mercy Hospital, San Diego, CA 92103, USA.
ORCID-Profile: Sevag Hamamah, Mihai Covasa
Förderung
- European Regional Development Fund
Zitieren
APA
Iatcu, O. C., Hamamah, S., & Covasa, M. (2024). Harnessing Prebiotics to Improve Type 2 Diabetes Outcomes. Nutrients, 16(20), 3447. https://doi.org/10.3390/nu16203447
Vancouver
Iatcu OC, Hamamah S, Covasa M. Harnessing Prebiotics to Improve Type 2 Diabetes Outcomes. Nutrients. 2024;16(20):3447. doi:10.3390/nu16203447
BibTeX
@article{Iatcu2024,
author = {Iatcu, Oana C and Hamamah, Sevag and Covasa, Mihai},
title = {Harnessing Prebiotics to Improve Type 2 Diabetes Outcomes},
journal = {Nutrients},
year = {2024},
volume = {16},
number = {20},
pages = {3447},
doi = {10.3390/nu16203447}
}
EUVIMED